Side-by-side comparison of AI visibility scores, market position, and capabilities
FY2024 Revenue: $11.174B (+9.17% YoY) | RevPAR +2.7% | 98,400 room openings in 2024 | Net unit growth: 7.3% | Franchise fees revenue +9.5% | System-wide RevPAR +3.7% | Americas RevPAR +3.1%
Hilton is a global hospitality company operating a portfolio of hotel brands ranging from luxury to budget-friendly accommodations across 122 countries. The company serves business and leisure travelers seeking reliable, comfortable lodging experiences supported by a comprehensive loyalty program and consistent service standards. Hilton has built brand loyalty through its Hilton Honors rewards program, diverse property portfolio including flagship Hilton Hotels, luxury Waldorf Astoria, and budget-friendly Hampton by Hilton, and a reputation for quality hospitality that makes it one of the world's largest and most recognized hotel chains.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.